Multidrug resistance ATP-binding cassette membrane transporters as targets for improving oropharyngeal candidiasis treatment

References

• Pankhurst CL. Candidiasis (oropharyngeal). Clin Evid. 2013;2013:1304
   Google Scholar
• Tscherner M Schwarzmüller T Kuchler K. Pathogenesis and antifungal drug resistance of the human fungal pathogen Candida glabrata. Pharmaceuticals. 2011;4:169-86.
   Google Scholar
• Farah CS Lynch N McCullough MJ. Oral fungal infections: An update for the general practitioner. Aust Dent J. 2010;55(Suppl 1):48-54.
   Google Scholar
• Cowen LE. The evolution of fungal drug resistance: Modulating the trajectory from genotype to phenotype. Nat Rev Microbiol. 2008;6:187-98.
   Google Scholar
• Shapiro RS Robbins N Cowen LE. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev. 2011;75:213-67.
   Google Scholar
• Cannon RD Lamping E Holmes AR Niimi K Baret PV Keniya MV et al Efflux-mediated antifungal drug resistance. Clin Microbiol Rev. 2009;22:291-321.
   Google Scholar
• Vandeputte P Ferrari S Coste AT. Antifungal resistance and new strategies to control fungal infections. Int J Microbiol. 2012;2012:713687
   Google Scholar
• Morschhauser J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol. 2010;47:94-106.
   Google Scholar
• Williams D Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011 3
   Google Scholar
• Dangi YS Soni M Namdeo KP. Oral candidiasis: A review. Int J Pharm Pharm Sci. 2010;2:36-41.
   Google Scholar
• Nasira S Vilas J Sarita K Basavraj N. Antifungal drug resistance in Candida species. Eur J Gen Med. 2013;10:254-8.
   Google Scholar
• Pfaller MA Diekema DJ Gibbs DL Newell VA Ellis D Tullio V et al Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366-77.
   Google Scholar
• Chen LM Xu YH Zhou CL Zhao J Li CY Wang R. Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations. J Int Med Res. 2010;38:536-45.
   Google Scholar
• Lamping E Monk BC Niimi K Holmes AR Tsao S Tanabe K et al Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae . Eukaryot Cell. 2007;6:1150-65.
   Google Scholar
• Wu CP Hsieh CH Wu YS. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol Pharm. 2011;8:1996-2011.
   Google Scholar
• Szakacs G Paterson JK Ludwig JA Booth-Genthe C Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219-34.
   Google Scholar
• Nikaido H. Multidrug resistance in bacteria. Ann Rev Biochem. 2009;78:119-46.
   Google Scholar
• Piddock LJ. Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol. 2006;4:629-36.
   Google Scholar
• Lubelski J Konings WN Driessen AJ. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev. 2007;71:463-76.
   Google Scholar
• Prasad R Goffeau A. Yeast ATP-binding cassette transporters conferring multidrug resistance. Ann Rev Microbiol. 2012;66:39-63.
   PubMed Web of Science ®Google Scholar
• Dean M Hamon Y Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. 2001;42:1007-17. [PubMed Abstract]
   Google Scholar
• Klein C Kuchler K Valachovic M. ABC proteins in yeast and fungal pathogens. Essays Biochem. 2011;50:101-19.
   Google Scholar
• Nagy Z Montigny C Leverrier P Yeh S Goffeau A Garrigos M et al Role of the yeast ABC transporter Yor1p in cadmium detoxification. Biochimie. 2006;88:1665-71.
   Google Scholar
• Prasad R Sharma M Rawal MK. Functionally relevant residues of Cdr1p: A multidrug ABC transporter of human pathogenic Candida albicans. J Amino Acids. 2011;2011:531412
   Google Scholar
• Linton KJ Holland IB. The ABC transporters of human physiology and disease: The genetics and biochemistry of ATP binding cassette transporters. 2011 USA: World Scientific
   Google Scholar
• Locher KP Lee AT Rees DC. The E. coli BtuCD structure: A framework for ABC transporter architecture and mechanism. Science. 2002;296:1091-8.
   Google Scholar
• Pinkett HW Lee AT Lum P Locher KP Rees DC. An inward-facing conformation of a putative metal-chelate-type ABC transporter. Science. 2007;315:373-7.
   Google Scholar
• Woo JS Zeltina A Goetz BA Locher KP. X-ray structure of the Yersinia pestis heme transporter HmuUV. Nat Struct Mol Biol. 2012;19:1310-5.
   Google Scholar
• Hollenstein K Frei DC Locher KP. Structure of an ABC transporter in complex with its binding protein. Nature. 2007;446:213-16.
   Google Scholar
• Oldham ML Khare D Quiocho FA Davidson AL Chen J. Crystal structure of a catalytic intermediate of the maltose transporter. Nature. 2007;450:515-21.
   Google Scholar
• Kadaba NS Kaiser JT Johnson E Lee A Rees DC. The high-affinity E. coli methionine ABC transporter: Structure and allosteric regulation. Science. 2008;321:250-3.
   Google Scholar
• Dawson RJ Locher KP. Structure of a bacterial multidrug ABC transporter. Nature. 2006;443:180-5.
   Google Scholar
• Ward A Reyes CL Yu J Roth CB Chang G. Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci U S A. 2007;104:19005-10.
   Google Scholar
• Aller SG Yu J Ward A Weng Y Chittaboina S Zhuo R et al Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 2009;323:1718-22.
   Google Scholar
• Li J Jaimes KF Aller SG. Refined structures of mouse P-glycoprotein. Protein Sci. 2014;23:34-46.
   Google Scholar
• Shintre CA Pike AC Li Q Kim JI Barr AJ Goubin S et al Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states. Proc Natl Acad Sci U S A. 2013;110:9710-5.
   Google Scholar
• Hohl M Briand C Grutter MG Seeger MA. Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. Nat Struct Mol Biol. 2012;19:395-402.
   Google Scholar
• Ward AB Szewczyk P Grimard V Lee C-W Martinez L Doshi R et al Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain. Proc Natl Acad Sci U S A. 2013;110:13386-91.
   Google Scholar
• Shapiro AB Ling V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem. 1997;250:130-7.
   Google Scholar
• Shapiro AB Fox K Lam P Ling V. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur J Biochem. 1999;259:841-50.
   Google Scholar
• Rutledge RM Esser L Ma J Xia D. Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: A molecular modeling study. J Struct Biol. 2011;173:333-44.
   Google Scholar
• Martinez L Arnaud O Henin E Tao H Chaptal V Doshi R et al Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein. FEBS J. 2014;281:673-82.
   Google Scholar
• Zhang L Ma S. Efflux pump inhibitors: A strategy to combat P-glycoprotein and the NorA multidrug resistance pump. ChemMedChem. 2010;5:811-22.
   Google Scholar
• Eckford PD Sharom FJ. ABC efflux pump-based resistance to chemotherapy drugs. Chem Rev. 2009;109:2989-3011.
   Google Scholar